Inventurus Knowledge Solutions Ltd Share Price – NSE  / BSE

IT - Software, Small Cap

Axis Bank Ltd, Alkyl Amines Chemicals Ltd, J B Chemicals & Pharmaceuticals Ltd, Uno Minda Ltd are among the other stocks to see a surge in volumes on BSE today, 14 May 2026.

Inventurus Knowledge Solutions Ltd clocked volume of 1.9 lakh shares by 10:47 IST on BSE, a 14.87 times surge over two-week average daily volume of 12786 shares. The stock gained 0.73% to Rs.1,688.95. Volumes stood at 5835 shares in the last session.

Axis Bank Ltd recorded volume of 65.1 lakh shares by 10:47 IST on BSE, a 11.98 times surge over two-week average daily volume of 5.43 lakh shares. The stock lost 1.14% to Rs.1,241.40. Volumes stood at 4.41 lakh shares in the last session.

Alkyl Amines Chemicals Ltd witnessed volume of 1.15 lakh shares by 10:47 IST on BSE, a 11.89 times surge over two-week average daily volume of 9684 shares. The stock increased 12.52% to Rs.1,838.15. Volumes stood at 3539 shares in the last session.

J B Chemicals & Pharmaceuticals Ltd witnessed volume of 1.56 lakh shares by 10:47 IST on BSE, a 9.35 times surge over two-week average daily volume of 16715 shares. The stock increased 0.77% to Rs.2,111.00. Volumes stood at 14362 shares in the last session.

Uno Minda Ltd saw volume of 2.34 lakh shares by 10:47 IST on BSE, a 6.42 fold spurt over two-week average daily volume of 36380 shares. The stock dropped 1.31% to Rs.1,111.40. Volumes stood at 56905 shares in the last session.

Powered by Capital Market - Live News

Net profit of Inventurus Knowledge Solutions rose 39.36% to Rs 205.97 crore in the quarter ended March 2026 as against Rs 147.80 crore during the previous quarter ended March 2025. Sales rose 18.47% to Rs 857.65 crore in the quarter ended March 2026 as against Rs 723.96 crore during the previous quarter ended March 2025.

For the full year,net profit rose 48.45% to Rs 721.55 crore in the year ended March 2026 as against Rs 486.06 crore during the previous year ended March 2025. Sales rose 19.89% to Rs 3193.79 crore in the year ended March 2026 as against Rs 2663.99 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Inventurus Knowledge Solutions will hold a meeting of the Board of Directors of the Company on 13 May 2026.

TruBridge is a fully integrated clinical and financial partner for small and mid-small size hospitals in the USA, offering electronic medical records (EMR) solutions and revenue cycle management (RCM) services.

This proposed strategic acquisition underscores a commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States.

The combined company would bring together IKS Health?s care enablement services and TruBridge?s expertise in revenue cycle management and electronic health record solutions, particularly for rural and community hospitals. Its goal is to strengthen local healthcare systems and improve access to essential care closer to patients? homes while supporting both ambulatory and acute care.

After the merger, the company will focus on improving workflows and operations by combining artificial intelligence with human oversight to address complex challenges.

As it integrates more clinical and financial data, the platform is expected to become more efficient and effective, helping healthcare organizations maintain financial stability and focus on patient care.

Overall, the organization will provide revenue cycle management, predictive analytics, and advanced EHR solutions to over 2,000 healthcare organizations and more than 150,000 clinicians to improve clinical, operational, and financial performance.

Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock. The acquisition has been approved by the Boards of Directors of IKS Health, IKS, and TruBridge, and is expected to close during the third calendar quarter of 2026, subject to the satisfaction of customary closing conditions.

IKS will finance the acquisition primarily through the incurrence of new indebtedness, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank, which is subject to satisfaction of customary conditions (including approval of the shareholders of IKS Health).

Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.

The company?s consolidated net profit jumped 41.37% to Rs 183.32 crore on 24.01% jump in revenue from operations to Rs 814.95 crore in Q3 FY26 over Q3 FY25.